Tag: Promising
India’s First CAR T-Cell Remedy Exhibits Promising Outcomes
India’s First CAR T-Cell Remedy Exhibits Promising Outcomes Why in Information? The outcomes of India’s first medical trial for Chimeric Antigen Receptor (CAR) T-cell remedy, printed in The Lancet Haematology, revealed a 73% response fee in sufferers with leukaemia and lymphoma. This breakthrough might revolutionise most cancers therapy in India. Relevance:GS-03 (Science and expertise) Key